• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2026, Vol. 28 ›› Issue (5): 682-689.DOI: 10.3969/j.issn.1671-2587.2026.05.003

Previous Articles     Next Articles

Experimental Study on Mesoporous Silica-Loaded Platelet-Rich Plasma Promoting Wound Healing

FENG Ziyang1, WANG Feifan1, CHEN Zhengli2, TU Xiaohua1, HUANG Weihua1, LI Jinqi1, GU Haihui1   

  1. 1Department of Transfusion Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai 200433;
    2Department of Burns, The First Affiliated Hospital of Naval Medical University, Shanghai 200433
  • Received:2026-09-02 Revised:2026-09-23 Online:2026-10-20 Published:2026-11-11

Abstract: Objective To investigate the feasibility and biosafety of mesoporous silica (MS) loaded with platelet-rich plasma (PRP), as well as its modulatory effect on the wound-healing capacity of PRP and the underlying molecular mechanisms. Methods Venous whole blood was harvested from rats. After anticoagulation, PRP was extracted via a two-step centrifugation protocol. The microstructure of mesoporous silica (MS) was characterized via scanning electron microscopy. PRP was loaded onto MS by freeze-drying method to fabricate PRP@MS composites. Subsequent in vitro experiments were performed to evaluate sustained-release behaviour and biocompatibility. Thirty SD rats with full-thickness dorsal skin wounds were randomly assigned into three groups (n=10 per group) using a random number table ∶ routine dressing group (treated with normal saline), PRP group (treated with PRP), and PRP@MS group (treated with PRP@MS). Dressings were performed every four days. Wound closure rates were quantified by pixel calculation on day 4 (n=10), day 8 (n=10) and day 12 (n=5). On day 8, five rats from each group were euthanised randomly. Wound tissues were harvested for histological detection, including immunohistochemical staining targeting CD31, high-mobility group box 1 (HMGB1) and Caspase 3, alongside immunofluorescence staining of silent information regulator 3 (SIRT3) and inducible nitric oxide synthase (iNOS). Results Scanning electron microscopy revealed abundant mesoporous structures in MS, endowing it with high specific surface area. Following 1∶1 loading ratio, PRP@MS group a sustained VEGF release profile lasting over 96 hours. exhibited sustained vascular endothelial growth factor (VEGF) release profile lasting over 96 hours. The PRP@MS group showed no intradermal irritation, hypersensitivity, pyrogenic reaction or acute toxicity, demonstrating favourable biocompatibility. Compared with the routine dressing group, hematoxylin-eosin (HE), Masson's trichrome and Sirius red-picric acid staining revealed both the PRP and PRP@MS groups had more abundant granulation tissue. higher collagen content, and a more uniform and organized collagen distribution . In cellular experiments, CCK-8 assay and ELISA results illustrated that compared with the PRP group, human skin fibroblast (HSF) cultured with PRP@MS exhibited markedly elevated proliferation activity and intracellular SIRT3 expression, accompanied by decreased iNOS levels (P<0.05). In animal experiments, compared with the routine dressing group and PRP group, the PRP@MS group displayed significantly elevated wound healing rates, counts of CD31 immunohistochemistry positive cells at day 4, 8 and 12 (P<0.05). The number of HMGB1 positive cells were lower in the PRP@MS group (P<0.05). Compared with the routine dressing group, Caspase 3 positive staining was substantially lower in the PRP@MS group (P<0.05), with no statistical difference observed between the PRP and PRP@MS groups. Immunofluorescence results showed that the mean optical density of SIRT3 was significantly increased, while that of iNOS was significantly decreased in the PRP@MS group compared with the other two groups (P<0.05). Conclusion PRP@MS composites can preserve PRP bioactivity, enhance its therapeutic efficacy and achieve sustained factor release. Compared with standalone PRP, PRP@MS exhibits superior biological activity and favourable biocompatibility, thereby facilitating wound healing comprehensively. And the mechanism of action is related to the upregulation of SIRT3 and downregulation of iNOS.

Key words: Mesoporous silica, Platelet rich plasma, Wound, SIRT3, iNOS

CLC Number: